Hudson Bay Capital Management
CATX icon

Hudson Bay Capital Management’s Perspective Therapeutics CATX Stock Holding History

Hudson Bay Capital Management’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-23,090
Closed -$96.3K – 1395
2026
Q1 		$96.3K Buy
+23,090
New +$97.6K ﹤0.01% 1184
2024
Q2 		– Sell
-85,000
Closed -$1.01M – 795
2024
Q1 		$1.01M Buy
+85,000
New +$725K 0.01% 541
2016
Q3 		– Sell
-1,020
Closed -$9K – 448
2016
Q2 		$9K Buy
+1,020
New +$9.76K ﹤0.01% 351

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Hudson Bay Capital Management's CATX Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Perspective Therapeutics (CATX) in Q2 2026, closing a stake of 23,090 shares — an estimated $96.3K sold.

Hudson Bay Capital Management first reported a position in CATX in Q2 2016 and held it in 3 quarters. The position peaked at $1.01M in Q1 2024. 132 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Perspective Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 23,090 Perspective Therapeutics shares in Q2 2026, an estimated $96.3K.
  • Hudson Bay Capital Management first reported a position in Perspective Therapeutics in Q2 2016 and held it in 3 quarters.
  • Hudson Bay Capital Management's Perspective Therapeutics position peaked at $1.01M in Q1 2024.
  • 132 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.